# The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)

> **NCT04573881** · NA · ACTIVE_NOT_RECRUITING · sponsor: **HistoSonics, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Liver Neoplasms
- Hepatocellular Carcinoma
- Liver Metastases

## Interventions

- **DEVICE:** HistoSonics System

## Key facts

- **NCT ID:** NCT04573881
- **Lead sponsor:** HistoSonics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-06-04
- **Primary completion:** 2022-09-29
- **Final completion:** 2027-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04573881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04573881, "The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT04573881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*